Modification of P3-cap. From tert-butylurea (compound 1) to

CN107573295B - Molecules and intermediates having pesticidal

Exploring the P2 and P3 ligand binding features for Hepatitis C

Hepatitis C: The Story of a Long Journey through First, Second

Exploring the P2 and P3 ligand binding features for Hepatitis C

Discovery of the HCV NS3/4A Protease Inhibitor (1R,5S)-N-[3-Amino

Pharmaceuticals, Free Full-Text

Discovery of (1R,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2,3

Discovery of the HCV NS3/4A Protease Inhibitor (1R,5S)-N-[3-Amino

Modification of P3-cap. From tert-butylurea (compound 1) to

Modification of P3-cap. From tert-butylurea (compound 1) to

PDF) The Discovery and Development of Boceprevir: A Novel, First

Modification of P3-cap. From tert-butylurea (compound 1) to